In the race to find more effective ways to treat cancer, Boise State biophysicist Daniel Fologea is working outside the rules of general mathematics that say one plus one equals two. In his world, one plus ...
Sep 12, 2014
5 / 5 (3) | 0
Just a week after the controversy over breast cancer drug Kadcyla, the inflexibilities within the UK's disparate drug approval systems have been pulled into sharp focus once again.
Aug 18, 2014
5 / 5 (1) | 0